Benmelstobart Plus Anlotinib and Chemotherapy Shows Benefit for Patients with Extensive-Stage Small-Cell Lung Cancer
"These results from the phase III trial are encouraging, as the combination of benmelstobart, anlotinib, and chemotherapy achieved historically long ...